Tesamorelin

Tesamorelin is a research-grade synthetic analogue of growth hormone-releasing hormone (GHRH). It binds to GHRH receptors on the anterior pituitary, stimulating endogenous growth hormone release. Modified with a hexenoyl group at the N-terminus to extend half-life and resist enzymatic degradation, Tesamorelin has become a reference compound for studying pulsatile GH secretion and its downstream effects on body composition and metabolism.

Available in 10mg vials.

Research applications include:

• GHRH receptor binding and pituitary stimulation studies
• Pulsatile growth hormone release pattern research
• Visceral adipose tissue and lipodystrophy research models
• IGF-1 axis and downstream metabolic signalling investigation
• Body composition and metabolic homeostasis studies

Product specifications:

• Form: Lyophilised powder
• Purity: ≥99% 
• Storage: −20°C, protected from light and moisture
• Available strength: 10mg

⚠ For research purposes only. This product is not intended for human or veterinary use, consumption, or self-administration. Must be handled by qualified professionals in a suitable laboratory environment. Not evaluated by the MHRA or any regulatory authority for therapeutic use.